Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Unoprostone Isopropyl in Dry AMD
NCT01379560Phase 2Completed
- Sponsor
- Sucampo
- Start
- May 2011
- Primary completion
- Dec 2011
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of unoprostone isopropyl in age-related macular degeneration (AMD), sponsored by Sucampo. Started May 2011; status: completed.
02
Drugs
unoprostone isopropyl
03
Conditions
age-related macular degeneration (AMD)
Beyond the preview
Go deeper on NCT01379560.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01379560.